5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
Life Science & Chemical Instrumentation is segmented by Technology, End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Contract Research Organization (CRO), Academia & Research Institutes) , and Geography
Fastest Growing Market:
Life science & chemical instrumentation market is primarily driven by the growing R&D activities and the growing burden of diseases worldwide. In Addition, The growing investment from the pharmaceutical industry in drug discovery and development will boost the demand for life science instruments for drug validation. Additionally, growing increasing public-private investments in life science research, technological advancements in analytical instruments are driving the market of life science instruments and chemicals. However, the lack of skilled professionals, the high cost of life science & chemical instrumentation is further impeding the growth of the market.
Instrumentation in Life Sciences & chemical addresses different aspects of instrumentation that hold the keys to cutting-edge research and innovative applications. Various kinds of conventional instruments have been used in the life sciences and chemistry fields. Technology for the life sciences and chemistry has advanced tremendously in the past ten years in both the public and private sectors.
|DNA Sequencers & Amplifiers|
|By End Users|
|Hospitals and Diagnostic Centers|
|Pharmaceutical and Biotechnology Companies|
|Contract Research Organization (CRO)|
|Academia & Research Institutes|
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
In North America, chemical instrumentation technology is used in many applications. Chemical instrumentation has proven to be an effective technology for final production testing, pharmaceutical applications, environmental monitoring, and food testing, among others. Other factors propelling the growth of North America life science and chemical instrumentation market, include increasing need for drug discovery, rising prevalence of chronic diseases, and augmented demand for rising food safety concerns. Moreover, the increasing focus on the development of new and improved drug assessment techniques, to discover highly complex drugs, has played a vital role in the evolution of innovative chemical methods in the region, which further drives the North America life science and chemical instrumentation market. For instance, in March 2020, Agilent introduced the next-generation clinical edition triple quadrupole LC/MS system, the K6460S, which is listed as a Class I medical device with the US Food and Drug Administration. This system is designed to improve the workflows in clinical labs.
To understand geography trends, Download Sample Report.
Market players in life science and chemical instrumentation market are focusing on the expansion of their product portfolios by adopting inorganic growth strategies such as acquisitions, mergers, and partnerships. While only a few companies are coming forward with innovative technologies and new product launches.
For instance, in February 2018 - Bruker Corporation acquired IRM2, a developer of high-speed infrared (IR) imaging microscopes based on quantum cascade laser (QCL) technology and in June 2017 - Bio-Rad Laboratories, Inc. announced the launch of CFX Maestro Software for CFX Real-Time Instruments, a complete workflow solution for real-time PCR data collection and analysis.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Spending on Pharmaceutical R&D
4.2.2 Technological Advancements in Analytical Instruments
4.2.3 Increasing Public-Private Investments in Life Science Research
4.3 Market Restraints
4.3.1 High Cost of the Instruments
4.3.2 Lack of Skilled Professionals
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Technology
5.1.2 DNA Sequencers & Amplifiers
5.1.3 Flow Cytometry
5.1.8 Other Technologies
5.2 By End Users
5.2.1 Hospitals and Diagnostic Centers
5.2.2 Pharmaceutical and Biotechnology Companies
5.2.3 Contract Research Organization (CRO)
5.2.4 Academia & Research Institutes
5.3.1 North America
184.108.40.206 United States
220.127.116.11 United Kingdom
18.104.22.168 Rest of Europe
5.3.3 Asia Pacific
22.214.171.124 South Korea
126.96.36.199 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
188.8.131.52 South Africa
184.108.40.206 Rest of Middle-East and Africa
5.3.5 South America
220.127.116.11 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies Inc.
6.1.2 Becton, Dickinson & Company
6.1.3 Bio-Rad Laboratories Inc.
6.1.4 Bruker Corporation
6.1.5 Danaher Corporation
6.1.6 F. Hoffmann-La Roche Ltd
6.1.7 Illumina Inc.
6.1.8 PerkinElmer Inc.
6.1.9 Thermo Fisher Scientific Inc.
6.1.10 Waters Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments